4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-13-053451
Chief Commercial Officer sold 13,860 shares at an average $3.76 ($52,058)
From the SEC's structured data for this filing
Trades in this filing
TEW WILLIAM P PHD · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-11-18 | Sale : show line 1 in the form | −5,000 | $3.77 | $18,851 | 42,125 | D |
| 2013-11-18 | Sale : show line 2 in the form | −5,000 | $3.76 | $18,808 | 37,125 | D |
| 2013-11-20 | Sale : show line 3 in the form | −3,860 | $3.73 | $14,400 | 33,265 | D |
| Open-market sales · 13,860 sh · avg $3.76 · $52,058 | ||||||
Loading xslF345X03/doc4.xml…